Leadership

Yong Chan Kim, PhD

Chief Executive Officer
  • Founder of TeraImmune, Inc
  • Ph.D. in Biochemistry, Chungnam National University
  • Former NIH Researcher and DoD USU Research Professor

Jay Park, PhD

Chief Operating Officer
  • Co-Founder of TeraImmune, Inc
  • Ph.D. in Biochemistry, Chungnam National University
  • Former NIH Researcher

Executive Advisors

Nick Hammond, PhD

Management Advisory
  • PhD, Medicinal Chem at U Mississippi
  • Co-founder at Albitech, Inc. (2006-2011)
  • Executive director at UMD system

Yan Su, PhD

Technical Advisory
  • 15 yr+ BD and R&D in I/O, autoimmune diseases, allergy and cell therapy

JHK BIOARCHITECT

Strategic BD partners

Scientific Advisors

Armand Keating, MD

  • Professor of Medicine, University of Toronto
  • Director, Cell Therapy Program, Princess Margaret Hospital/Ontario Cancer Institute

Collaborating PIs

Ethan M. Shevach, MD, CRADA PI

  • Senior principle investigator, NIAID, NIH
  • Discovered Treg cells Nobel Prize candidate

David W. Scott, PhD, CRADA PI

  • Vice chair for Research, MED, Professor, USU
  • 200+ research papers on immunological tolerance and its application in autoimmune diseases

Steven Jacobson, PhD, CRADA PI

  • Senior investigator, NINDS, NIH
  • Neuroimmunology and Neurovirology Division involved in 3 clinical trials at NIH